SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $555,660 | +87.1% | 27,000 | +255.9% | 0.00% | – |
| Q3 2022 | $297,000 | +42.1% | 7,586 | +20.4% | 0.00% | – |
| Q1 2022 | $209,000 | -95.1% | 6,300 | -91.6% | 0.00% | -100.0% |
| Q2 2021 | $4,278,000 | +191.0% | 75,300 | +213.1% | 0.00% | +300.0% |
| Q3 2020 | $1,470,000 | -51.8% | 24,051 | +10.7% | 0.00% | -66.7% |
| Q3 2019 | $3,047,000 | -29.0% | 21,723 | -7.3% | 0.00% | -40.0% |
| Q2 2019 | $4,289,000 | -71.9% | 23,424 | -75.5% | 0.01% | -70.6% |
| Q1 2019 | $15,237,000 | +275.9% | 95,800 | +126.4% | 0.02% | +183.3% |
| Q4 2018 | $4,053,000 | +28.0% | 42,313 | +88.7% | 0.01% | +50.0% |
| Q3 2018 | $3,167,000 | +451.7% | 22,421 | +511.8% | 0.00% | +300.0% |
| Q2 2018 | $574,000 | -87.6% | 3,665 | -87.3% | 0.00% | -83.3% |
| Q1 2018 | $4,637,000 | +78.7% | 28,794 | +82.8% | 0.01% | +100.0% |
| Q4 2017 | $2,595,000 | -16.9% | 15,754 | -68.6% | 0.00% | -40.0% |
| Q3 2017 | $3,121,000 | -26.1% | 50,100 | -5.5% | 0.01% | -37.5% |
| Q2 2017 | $4,221,000 | +510.9% | 52,996 | +253.3% | 0.01% | +700.0% |
| Q3 2016 | $691,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |